Among its recommendations, the association said Congress should work to strengthen shortage disclosure requirements for drugmakers, incentivize manufacturers to make contingency plans in case of a shortage and assess drug shortages as a national security threat.
The FDA should work to establish a manufacturing quality rating system, improve its drug shortages list, develop a list of critical drugs and disclose more information on the quality of outsourcing facilities that compound drugs during a shortage, it said.
Read the full news release here.
More articles on pharmacy:
Hospital-owned drug company attracts 12 more health systems
How nurses are becoming integral to pharma marketing: 7 notes
4 tips for managing drug spend from Alameda Health System’s Dr. Yi-Chih Peng
